Studies to reduce unnecessary medication use in frail older adults: A systematic review

Drugs and Aging

Volumn 30, Issue 5, 2013, Pages 285-307

  Tjia, Jennifer ^a   Velten, Sarah J ^b   Parsons, Carole ^c   Valluri, Sruthi ^d   Briesacher, Becky A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

AGED HOSPITAL PATIENT; CLINICAL EFFECTIVENESS; COMMUNITY CARE; CONSENSUS; DRUG INDICATION; DRUG USE; DRUG UTILIZATION; EMBASE; FRAIL ELDERLY; FUNCTIONAL STATUS; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HOME CARE; HOSPICE CARE; HUMAN; LIFE EXPECTANCY; LONG TERM CARE; MEDLINE; NURSING HOME PATIENT; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; SYSTEMATIC REVIEW;

EID: 84876893908     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-013-0064-1     Document Type: Review

References (64)

1. Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166:605-9.
2. Lee SP, Bain KT, Maio V. Appropriate discontinuation of medications at the end of life: a need to establish consensus criteria. Am J Med Qual. 2007;22:393-4.
3. Stevenson J, Abernethy AP, Miller C, Currow DC. Managing comorbidities in patients at the end of life. Br Med J. 2004;329:909-12. (Pubitemid 39422944)
4. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003;20:817-32. (Pubitemid 37159599)
5. Marcum ZA, Handler SM, Wright R, Hanlon JT. Interventions to improve suboptimal prescribing in nursing homes: A narrative review. Am J Geriatr Pharmacother. 2010;8:183-200.
6. Verrue CL, Petrovic M, Mehuys E, Remon JP. Vander Stichele R. Pharmacists' interventions for optimization of medication use in nursing homes: a systematic review. Drugs Aging. 2009;26:37-49.
7. McGhan WF, Wertheimer AI, Marttila JK. Assessing the need for pharmacist-conducted drug regimen reviews in skilled nursing and intermediate care facilities. Contemp Pharm Pract. 1980;3:203-9.
8. Forsetlund L, Eike MC, Gjerberg E, Vist GE. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomized controlled trials. BMC Geriatr. 2011;11:16. http://www.biomedcentral.com/1471-2318/11/16
9. Cruz-Jentoft AJ, Boland B, Rexach L. Drug therapy optimization at the end of life. Drugs Aging. 2012;29:511-21.
10. Omnibus Budget Reconciliation Act of 1987 [OBRA-87], U.S.C. § 1395i-3 (1987).
11. Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in palliative care as death approaches. J Am Geriatr Soc. 2007;55:590-5. (Pubitemid 46496589)
12. Tjia J, Rothman MR, Kiely DK, Shaffer ML, Holmes HM, Sachs GA, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc. 2010;58:880-8.
13. Blass DM, Black BS, Phillips H, Finucane T, Baker A, Loreck D, et al. Medication use in nursing home residents with advanced dementia. Int J Geriatr Psychiatry. 2008;23:490-6. (Pubitemid 351722109)
14. Holmes HM, Sachs GA, Shega JW, Hougham GW. Cox Hayley D, Dale W. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc. 2008;56:1306-11.
15. Bell CM, Brener SS, Gunraj N, Huo C, Bierman AS, Scales DC, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA. 2011;306:840-7.
16. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045-51.
17. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-32.
18. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
19. Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51:257-65. (Pubitemid 32396417)
20. Brown BK, Earnhart J. Pharmacists and their effectiveness in ensuring the appropriateness of the chronic medication regimens of geriatric inpatients. Consult Pharm. 2004;19:432-6. (Pubitemid 38656235)
21. Flood KL, Carroll MB, Le CV, Brown CJ. Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit. Am J Geriatr Pharmacother. 2009;7:151-8.
22. Ray WA, Taylor JA, Meador KG, Lichtenstein MJ, Griffin MR, Fought R, et al. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med. 1993;153:713-21. (Pubitemid 23094850)
23. Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992;327:168-73.
24. Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc. 1998;46:77-82. (Pubitemid 28037677)
25. Elliott RA, Woodward MC, Oborne CA. Improving benzodiazepine prescribing for elderly hospital inpatients using audit and multidisciplinary feedback. Intern Med J. 2001;31:529-35.
26. Gurwitz JH, Noonan JP, Soumerai SB. Reducing the use of H2-receptor antagonists in the long-term-care setting. J Am Geriatr Soc. 1992;40:359-64.
27. Stein CM, Griffin MR, Taylor JA, Pichert JW, Brandt KD, Ray WA. Educational program for nursing home physicians and staff to reduce use of non-steroidal anti-inflammatory drugs among nursing home residents: a randomized controlled trial. Med Care. 2001;39:436-45. (Pubitemid 33702446)
28. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients. Clinical Pharm Ther. 2011;89:45-854.
29. Lang PO, Vogt-Ferrier N, Hasso Y, et al. Interdisciplinary geriatric and psychiatric care reduces potentially inappropriate prescribing in the hospital: interventional study of 150 actuely ill elderly patients with mental and somatic comorbid conditions. JAMDA. 2012;13:406.e1-7.
30. Davis RG, Hepfinger CA, Sauer KA, Wilhardt MS. Retrospective evaluation of medication appropriateness and clinical pharmacist drug therapy recommendations for home-based primary care veterans. Am J Geriatr Pharmacother. 2007;5:40-7. (Pubitemid 47099501)
31. Stuijt CC, Franssen EJ, Egberts AC, Hudson SA. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging. 2008;25:947-54.
32. Bergkvist A, Midlov P, Hoglund P, Larsson L, Eriksson T. A multi-intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM-Landskrona Integrated Medicines Management. J Eval Clin Pract. 2009;15:660-7.
33. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004;2:257-64. (Pubitemid 40378780)
34. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, et al. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing. 2004;33:612-7. (Pubitemid 39504296)
35. Owens NJ, Sherburne NJ, Silliman RA, Fretwell MD. The Senior Care Study. The optimal use of medications in acutely ill older patients. J Am Geriatr Soc. 1990;38:1082-7.
36. Suhrie EM, Hanlon JT, Jaffe EJ, Sevick MA, Ruby CM, Aspinall SL. Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing. Am J Geriatr Pharmacother. 2009;7:20-5.
37. Hellstrom LM, Bondesson A, Hoglun P, Midlov P, Holmdahl L, Rickhag E, Eriksson T. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67:741-52.
38. Allard J, Hebert R, Rioux M, Asselin J, Voyer L. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ. 2001;164:1291-6. (Pubitemid 32702039)
39. Jeffery S, Ruby CM, Twesky J, Hanlon JT. Effect of an interdisciplinary team on suboptimal prescribing in a long-term care facility. Consult Pharm. 1999;14:1386-91.
40. Schmader KE, Hanlon JT, Pieper CF, Sloane R, Ruby CM, Twersky J, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004;116:394-401. (Pubitemid 38299484)
41. Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007;55:658-65. (Pubitemid 46668957)
42. Lee J, McPherson ML. Outcomes of recommendations by hospice pharmacists. Am J Health Syst Pharm. 2006;63:2235-9. (Pubitemid 44851437)
43. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial. Med Care. 1992;30:646-58.
44. Lucas C, Glare PA, Sykes JV. Contribution of a liaison clinical pharmacist to an inpatient palliative care unit. Palliat Med. 1997;11:209-16. (Pubitemid 27250000)
45. Mannheimer B, Ulfvarson J, Eklof S, Bergqvist M, Andersen-Karlsson E, Pettersson H, et al. Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. Eur J Clin Pharmacol. 2006;62:1075-81. (Pubitemid 44786500)
46. Triller DM, Clause SL, Briceland LL, Hamilton RA. Resolution of drug-related problems in home care patients through a pharmacy referral service. Am J Health Syst Pharm. 2003;60:905-10. (Pubitemid 36749015)
47. Halvorsen KH, Ruths S, Granas AG, Viktil KK. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scand J Prim Health Care. 2010;28:82-8.
48. Brulhart MI, Wermeille JP. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm. 2011;33:549-57.
49. Olsson IN, Curman B, Engfeldt P. Patient focused drug surveillance of elderly patients in nursing homes. Pharmacoepidemiol Drug Saf. 2010;19:150-7.
50. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9:430-4. (Pubitemid 46979143)
51. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med. 2010;170:1648-54.
52. Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention. J Am Geriatr Soc. 2005;53:1912-20. (Pubitemid 41826068)
53. Furniss L, Burns A, Craig SK, Scobie S, Cooke J, Faragher B. Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial. Br J Psychiatry. 2000;176:563-7. (Pubitemid 30353658)
54. Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, et al. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ. 2006;332:756-61. (Pubitemid 44365651)
55. Alexander GC, Sayla MA, Holmes HM, Sachs GA. Prioritizing and stopping prescription medicines. CMAJ. 2006;174:1083-4.
56. Woodward M. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323-8. (Pubitemid 38035980)
57. Scott IA, Gray LC, Martin JH, Mitchell CA. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125:529-37.
58. Tjia J, Givens JL. Ethical framework for medication discontinuation in nursing home residents with limited life expectancy. Clin Geriatr Med. 2012;28:255-72.
59. le Grand A, Hogerzeil H, Haaijer-Ruskamp F. Intervention research in rational use of drugs: a review. Health Policy Plan. 1999;14:89-102. (Pubitemid 29280990)
60. Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56:1946-52.
61. Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med. 1995;123:195-204.
62. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the clinician's guide. 2nd ed. New York: McGraw-Hill; 2004. p. 394.
63. Ruths S, Viktil KK, Blix HS. Classification of drug-related problems. Tidsskr Nor Laegeforen. 2007;127:3073-6.
64. Howard R, Ballard C, O'Brien J, Burns A. Guidelines for the management of agitation in dementia. Int J Geriatr Psychiatry. 2001;16:714-7. (Pubitemid 32754932)